KardiaMobile 6L Max delivers more ECG analysis than any other consumer ECG app to provide patients and their healthcare providers with an unmatched cardiac care solution.
KardiaAlert Feature uses AI to provide longitudinal tracking, instant clinical analysis, and real-time monitoring and feedback from healthcare providers.
Mountain View, Calif., May 6, 2025 — AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its most advanced personal cardiac health system to date, the KardiaMobile® 6L Max, alongside the debut of KardiaAlert — a first-of-its kind AI-powered monitoring feature–available exclusively to KardiaCare subscribers. With KardiaMobile 6L Max and KardiaAlert, users gain access to a groundbreaking artificial intelligence (AI) tool that monitors heart rhythm changes over time and alerts patients to changes, helping them take action.
“AliveCor is committed to innovating for patients, providers and the healthcare industry,” said Sanjay Voleti, CBO of AliveCor. “With the launch of KardiaMobile 6L Max and the integration of KardiaAlert, we are proud to provide patients and clinicians with the most comprehensive AI-based heart health system available over-the-counter.”
KardiaMobile 6L Max, the most complete personal ECG system
Heart disease often progresses slowly and without symptoms, leading to delays in diagnosis that make preventative care impossible. As such, the demand for remote cardiac monitoring is growing rapidly, especially due to an aging global population and increase in cardiac conditions worldwide. KardiaMobile 6L Max responds to this critical need by offering a unique pairing of KardiaCare membership and AliveCor’s most innovative ECG monitor to provide users with affordable and accessible peace of mind.
Providing in-depth reporting on ECGs, blood pressure, and weight data with remote access to certified cardiologists, KardiaMobile 6L Max includes a KardiaMobile 6L device and a one-year subscription to KardiaCare, which now includes the KardiaAlert feature.
KardiaAlert Feature detects changes that may otherwise be missed
KardiaAlert is a new feature that uses AI to compare every ECG taken against an established baseline ECG and scans for subtle changes over time (even subtle ones) that are not visible in a single recording, and could potentially indicate a serious condition or lead to a cardiac event. If a change is potentially detected, the ECG data is sent to a clinician for further review. KardiaAlert alerts patients to changes in their ECG–no matter how subtle–so that they can have more informed conversations with their healthcare provider.
“KardiaMobile 6L Max identifies up to 20 arrhythmias with a clinician review—more than any other personal ECG—all without doctor’s appointments, waiting rooms, or lengthy tests. Meanwhile, KardiaAlert uses AI to monitor important heart rhythm changes over time,” said Dr. David E. Albert, founder and chief medical officer of AliveCor. “These next-generation functionalities enable cardiologists to spend more time on patients who require in-person care while simultaneously empowering patients to remotely manage their care with peace of mind.”
KardiaMobile 6L Max is available for purchase at Kardia.com and coming soon to Amazon. To learn more about KardiaAlert, please visit https://kardia.com/kardiaalert/.
About AliveCor
AliveCor, Inc., the leading provider of FDA-cleared personal electrocardiogram (ECG) technology, is transforming cardiology with its medical-grade AI solutions. AliveCor is committed to providing innovative devices and services that empower patients and physicians with personalized and actionable heart data. With over 300 million ECGs recorded, the company’s Kardia devices are the most clinically validated personal ECGs in the world and can remotely detect six of the most common heart arrhythmias in just 30 seconds. The Kardia 12L ECG System, company’s first offering designed exclusively for use by healthcare providers, is powered by KAI 12L to detect 35 cardiac conditions (14 arrhythmias and 21 morphologies). AliveCor's enterprise platform allows third-party providers to manage their patients’ and customers’ heart conditions simply using state-of-the-art tools that provide easy front-end and back-end integration to AliveCor technologies, addressing gaps in care and improving the treatment experience for patients across a range of disease areas. AliveCor is a privately held company headquartered in Mountain View, Calif. For more information, visit alivecor.com and follow us on LinkedIn, X, Instagram and Facebook.
Media Contacts
Su Leeslee191@alivecor.com
Kate Conway
Kate.Conway@MBoothHealth.com